Skip to main content
. 2021 Apr 29;23:52. doi: 10.1186/s13058-021-01429-4

Fig. 6.

Fig. 6

The mass characteristic frequency measured before NACT, at the mid-course of NACT, and after NACT but before surgery for different molecular subtypes: ac Luminal A type, df Luminal B (HER2-) type, gi Luminal B (HER2+) type, jl HER2+ type, and mo TN type. NACT, neoadjuvant chemotherapy; TN, triple-negative